Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 224

The DOI matches its Crossref record.

Management of Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease

Pirson, Yves, Chauveau, Dominique, Torres, Vicente · 2002 · Journal of the American Society of Nephrology

Abstract

The association of intracranial aneurysm (ICA) and autosomal dominant polycystic kidney disease (ADPKD) has been known for many years. Its prevalence has only been estimated reliably over the past decade, thanks to the development of noninvasive detection techniques, mainly magnetic resonance (MR) angiography. A prevalence of 8% of asymptomatic ICA has been derived from three prospective series totaling 266 patients (1–4), i.e., a rate four to five times above that found in the general population (5). Although this association has been attributed in the past to the occurrence of hypertension in many affected patients, several lines of evidence strongly suggest a causal role of the mutated ADPKD gene. PKD1, the gene responsible for ∼85% of ADPKD cases, encodes polycystin 1, an 11-pass membrane protein with a large extracellular region mediating cell-cell and cell-matrix interactions (6). PKD2, which accounts for the vast majority of the remaining cases, encodes polycystin 2, a 6-pass membrane protein with homology to voltage-activated calcium channels (7). Polycystin 2 is believed to interact with polycystin 1 to transduce signals from extracellular ligands (8). Recent experimental evidence has suggested that both PKD1 and PKD2 play a role in the structural integrity of blood vessels. Mouse embryos homozygous for a targeted mutation in the mouse homolog of PKD1 exhibit vascular leaks and rupture of blood vessels, leading to death in utero (9). Focal hemorrhages have also been noticed in mouse embryos homozygous for a PKD2 null allele (10). In humans, both polycystin 1 and polycystin 2 are strongly expressed in vascular smooth-muscle cells of normal adult elastic arteries, whereas a staining of variable intensity is observed in the walls of ICA specimens from patients with as well as without ADPKD (11,12). Polycystins could thus be instrumental in the functional interaction between arterial smooth-muscle cells and adjacent elastic tissue or endothelial cells; a mutation in their genes could disrupt this interaction and weaken the vessel wall (13). Specific types of mutation might predispose to the development of ICA, as suggested by some clustering of ICA in families that carry both PKD1 (14) and PKD2 (15), as well as by the identification of the same PKD1 mutation in two different pedigrees with ICA affecting one and three members, respectively (16). However, both the absence of ICA in other relatives with ADPKD within such families as well as the wide intrafamilial variability in the occurrence and/or severity of this (and other) manifestation(s) of ADPKD indicate that other factors also play a role in the formation and rupture of ICA. Somatic mutations in the normal PKD allele (“the second hit”) and/or modifying genes could be such factors. Among the latter, the gene(s) responsible for non-ADPKD familial ICA, as yet not identified, might be involved (ICA is said to be familial when two or more first-degree relatives are affected) (17,18). The contributory role of acquired factors should also be considered: in the general population, cigarette smoking and arterial hypertension have indeed been recognized as the most significant risk factors for both the development and the rupture of sporadic as well as familial ICA (19,20). The natural history of ICA in ADPKD remains largely unknown. We fortunately know that all ICA do not rupture. When they do, this event entails a 35% to 55% risk of combined case fatality and morbidity (14,21). We review this complication, focusing on clinical presentation, diagnostic work-up, and current management. We then discuss the pros and cons of screening patients with ADPKD for asymptomatic ICA. Because data for an ADPKD population are quite often unavailable, we frequently refer to information on sporadic and familial ICA obtained in the general population, acknowledging the limitations of such extrapolations. Aneurysm Rupture The incidence of ICA rupture in patients with ADPKD has been estimated to be ∼1/2000 person-years in Rochester (21), i.e., a rate five times higher than in the general population (19). This 5/1 ratio roughly parallels that of the prevalence of ICA, which suggests that the risk of rupture of ICA among patients with ADPKD is quite similar to that observed in the general population. Demographics The profile of the patient with ADPKD admitted for ICA rupture has been delineated on the basis of three studies that included 191 patients (14,17,21,22). Age at the time of ICA rupture averages 41 yr. This is close to that observed in other familial forms of ICA but a decade lower than that reported in the sporadic form (17). In our series, 10% of the patients are <21 yr old (14). Occasionally, ICA rupture is the presenting manifestation of ADPKD. As expected from the mean age at rupture, 54% of the patients still have a normal renal function at that time, and 26% had a BP within the normal range before rupture (22). The prevalence of clinical manifestations related

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.v131269

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 224

Metadata

Authors
Pirson, Y., Chauveau, D., & Torres, V.
Venue
Journal of the American Society of Nephrology
Published
2002-01
Volume
13
Issue
1
Pages
269-276
ISSN
1046-6673 (ISSN-L)
OpenAlex
W1935323592
Cited by
224
References
0
FWCI
3.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease. https://app.cochat.ai/papers/10.1681/asn.v131269
The paper
Pirson, Y., Chauveau, D., & Torres, V. (2002). Management of Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v131269

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.